Table 3.
Summary of baseline to year 1 outcomes for the whole early rheumatoid arthritis group
| Outcome | Geometric mean (95% CI) Baseline |
Geometric mean (95% CI) 1 year |
Ratio (95% CI), P value |
| AD (10−3 mm Hg−1) | 3.0 (2.7 to 3.4) | 3.6 (3.1 to 4.1) | 1.2 (1.1 to 1.3), <0.01 |
| LVEF (%) | 60.3 (59.1 to 61.6) | 59.9 (58.5 to 61.5) | 1.0 (1.0 to 1.0), 0.54 |
| LVLS (cm/s) | 1.1 (1.1 to 1.2) | 1.1 (1.1 to 1.2) | 1.0 (1.0 to 1.1), 0.84 |
| PLVTw (°) | 14.9 (13.9 to 15.8) | 14.6 (13.7 to 15.7) | 1.0 (0.9 to 1.1), 0.69 |
| LV mass (g) | 78.2 (73.7 to 82.9) | 81.4 (76.3 to 86.9) | 1.0 (1.0 to 1.1), 0.01 |
| Native T1 (ms) | 1183.92 (1174.44 to 1193.48) | 1185.39 (1168.99 to 1202.02) | 1 (0.99 to 1.02), 0.87 |
| ECV (%) | 27.2 (26.4 to 28.1) | 26.4 (25.6 to 27.1) | 1.0 (0.9 to 1.0), 0.06 |
n=81 with imputation for missing baseline or follow-up values.
AD, aortic distensibility; ECV, myocardial extracellular volume; LVEF, left ventricular ejection fraction; LVLS, left ventricular longitudinal strain; LV mass, left ventricular mass; PLVTw, peak left ventricular twist.